METABOLIC

Meridian

Personalized Tirzepatide+ Injectable

from $249 / month

Meridian is a physician-supervised tirzepatide program formulated with a supportive cofactor (glycine or niacinamide), supporting appetite control through dual-receptor activation.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, engaging two complementary metabolic pathways. With supportive cofactors and ongoing clinician oversight, Meridian is designed for meaningful, sustained metabolic outcomes.

Tirzepatide activates both the GIP and GLP-1 receptors, two hormone pathways involved in appetite, blood sugar, and how the body stores and uses energy. Engaging both can support stronger appetite control than GLP-1 alone. Your formulation includes a supportive cofactor — either glycine or niacinamide, as determined by your clinician — to complement the protocol. Your clinician titrates your dose gradually to balance results with tolerability.

Dual GIP and GLP-1 receptor activation
Supports strong appetite control and reduced cravings
Helps promote sustainable weight regulation
Supports healthy blood sugar balance
Gradual, clinician-guided dose titration

Nausea, especially when starting or increasing the dose
Constipation or diarrhea
Mild fatigue or headache
Temporary injection site redness or discomfort

Personal or family history of medullary thyroid carcinoma or MEN 2
Pregnancy or breastfeeding
History of pancreatitis
Known hypersensitivity to tirzepatide or any formulation component

A clinician reviews your intake first. If clinically appropriate, they may prescribe medication. Not all intakes are guaranteed to result in a filled prescription. You are not charged unless a clinician issues a prescription issued and filled. Actual vial appearance, contents, and dosage may vary based on your individual prescription as determined by your clinician. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. Individual results vary.